Switzerland-based drugs company Debiopharm Group said it would support the country’s national pre-seed fund, Venture Kick, to help business ideas at Switzerland’s institutes of higher learning and universities. Debiopharm is the first private company to join the ranks of the five foundations – Gebert Rüf Stiftung, Ernst Gohner Stiftung, OPO-Stiftung, Avina Stiftung and Fondation 1796…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
